Author(s): Tang YB, Lu D, Chen Z, Hu C, Yang Y, et al.
Fifteen novel sulfathiazole-related compounds were designed as PTP1B inhibitors based on a previously reported allosteric inhibitor (1) of PTP1B. These compounds were synthesized and evaluated against human recombinant PTP1B. Six compounds (3, 4, 8 and 14-16) exhibited significant inhibitory activity against PTP1B. The most active compound (16) showed IC50 value of 3.2 μM and kinetic analysis indicated that it is a non-competitive inhibitor of PTP1B. Furthermore, compound 16 demonstrated excellent selectivity to PTP1B over other PTPs. It also displayed in vivo insulin sensitizing effect in the insulin resistant mice.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/23499238
Author(s): Lapchak PA, McKim JM Jr
Author(s): Lapchak PA
Author(s): Lapchak PA, Schubert DR, Maher PA
Author(s): Valera E, Dargusch R, Maher PA, Schubert D
Author(s): Liu Y, Dargusch R, Maher P, Schubert D
Author(s): Panzhinskiy E, Hua Y, Lapchak PA, Topchiy E, Lehmann TE, et al.
Author(s): Narumoto O, Matsuo Y, Sakaguchi M, Shoji S, Yamashita N, et al.
Author(s): Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, et al.
Author(s): Moskowitz MA, Lo EH, Iadecola C
Author(s): Shinde RN, Sobhia ME
Author(s): Liu Z, Chai Q, Li YY, Shen Q, Ma LP, et al.
Author(s): Tobin JF, Tam S
Author(s): McCain DF, Wu L, Nickel P, Kassack MU, Kreimeyer A, et al.